Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
TriSalus Life Sciences, Inc.
Insider Bryan F. Cox of TriSalus Life Sciences reported a change in beneficial ownership of company securities effective October 5, 2026. This filing is a Form 4 statement detailing the transaction.…more
TriSalus Life Sciences, Inc.
Insider Richard Marshak of TriSalus Life Sciences, Inc. reported changes in his beneficial ownership of securities effective October 5, 2026. This filing serves as an official Form 4 statement regarding the insider's equity position.…more
TriSalus Life Sciences, Inc.
Insider Jennifer Stevens of TriSalus Life Sciences reported a change in beneficial ownership of securities as of October 5, 2026. This filing serves as a standard disclosure of executive equity holdings and does not involve any capital raising or issuance events affecting the company's financial structure.…more
16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
TriSalus Secures FDA Clearance For TriNav Advance
TriSalus Life Sciences received FDA 510(k) clearance for its new TriNav Advance device, expanding its pressure-enabled drug delivery portfolio. While the regulatory milestone enhances the company's oncology offerings, the stock currently faces technical resistance near key price levels.…more
●●●●●●●● ●●●●● ●●●●●●
TriSalus Life Sciences has been granted FDA 510(k) clearance for its TriNav advance delivery device. The company plans to initiate a limited market release in the coming weeks.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.